Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
  Pharmaceutical Technology Europe E-Alert
 
30 November 2012

IN THIS ISSUE
Black box labeling
GSK subsidiaries
EMA transparency
Protein refolding technology
Twitter

Europe Considers Black Box Warnings for Certain Medicines
The European Commission (EC) is seeking to introduce a black symbol to identify medicines that are subject to additional monitoring. A public consultation has been launched for stakeholders to comment on the phasing-in requirements for such a symbol. More...
 
GSK Plans to Increase Stake in India and Nigeria Subsidiaries
GlaxoSmithKline intends to increase ownership of its publicly-listed subsidiary in India, from 43.2% to up to 75%, and to increase ownership in GlaxoSmithKline Consumer Nigeria PLC from 46.4% to 80%. More...
 
EMA Workshop Targets Clinical Data Transparency
The European Medicines Agency has conducted a workshop on clinical-trial data and transparency in London following the agency’s decision earlier this year to proactively publish all data from clinical trials and enable interested parties to access full data sets. More...
 
Boehringer Ingelheim Licenses High-Pressure Protein Refolding Technology
Boehringer Ingelheim has entered into a non-exclusive technology and commercial license option agreement with BaroFold. Under the terms of the agreement, Boehringer Ingelheim will license BaroFold's pressure-enabled manufacturing technology. More...
 
Get the Latest Updates on Twitter
We regularly tweet the latest news and rumours hitting the web about the pharmaceutical industry. Follow us to keep up to date. More...
Key Topics:

Latest blog posts
Personalised Medicine: Pharma's Golden Era?
In Favour of Needle-Free Injections
Towards Greater Transparency of Clinical Trials
More blog posts

Latest articles
Will Europe Discourage the Launch of New Alzheimer's Drugs?
Developing a Comprehensive Approach for Preventing Metal Contamination of Pharmaceutical Products
A Troubleshooting Guide for Topical Drug Manufacturing
More articles

Upcoming events
New York Pharma Forum 23rd Annual General Assembly (7 December | US)
5th Annual Contract Manufacturing (7–8 December | UK)
Pre-Filled Syringes (28–29 January | UK)
More events

Products/Service Profiles
Shimadzu

Nexera X2 – X-ceptional insights
Ultra-high sensitivity, expanded flexibility, increased stability and robustness - the new Nexera X2 UHPLC system targets routine analysis and applications in highly regulated environments demanding complex system setups. Read More

Survey
2012 has been touted as a crucial year of the so-called patent cliff. Do you think the impact of patent expiries has been better or worse than expected?
 
Better 46%
 
 
Worse 14%
     
 
As predicted 40%

This week we would like to know...

Compared with 2011, has your company attended more or less industry trade shows in 2012?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.